Why Does My Ankle Still Hurt After a Sprain?
Ankle sprains happen when the foot twists or rolls, stretching or tearing the supporting ligaments. While ligament damage is often the most obvious injury, the articular cartilage inside the joint can also be affected at the time of the sprain. Because cartilage has limited blood supply, it recovers slowly, and wear within the joint can lead to ongoing pain, swelling, stiffness, or a feeling of instability long after the ligament injury has settled. Imaging — usually an MRI — can reveal whether cartilage damage is contributing to persistent symptoms.
What Is ChondroFiller?
ChondroFiller is a CE Class III-marked medical device: an acellular type I collagen hydrogel scaffold made by Meidrix Biomedicals in Germany. When introduced into a joint it self-gels within a few minutes, settling over worn cartilage surfaces to form a supportive layer. Because it is collagen-based, it has biological potential — the scaffold may recruit the patient's own progenitor cells over time. The CE marking and published evidence relate to ChondroFiller as the device itself.
The ChondroFiller Injection: A Non-Surgical Outpatient Procedure
The ChondroFiller injection is the non-surgical delivery pathway for this scaffold. It is performed as an ultrasound-guided outpatient procedure, typically under local anaesthetic, without the need for a theatre, incision, or general anaesthetic. The collagen scaffold is injected directly into the ankle joint, where it may settle over worn surfaces, helping to cushion the joint and reduce mechanical irritation.
The ankle is well suited to this approach because it is an accessible joint and cartilage damage here often results from trauma such as sprains rather than generalised arthritis. The procedure takes a short time, and patients can usually mobilise the same day, though a structured rehabilitation plan is still important.
The gel can absorb load and adapt to the forces inside a joint (Weizel et al., 2020). It is best understood as a joint-preserving, biologically supportive intervention rather than a guaranteed structural repair. It does not cure or reverse arthritis, and outcomes vary between individuals.
When Might the ChondroFiller Injection Be Considered?
The injection may be considered for patients with persistent ankle pain where imaging has confirmed cartilage damage and standard conservative measures — physiotherapy, analgesia, activity modification — have not produced adequate relief. It is not suitable for all patients; contraindications and the severity and location of the defect will influence whether the injection is appropriate.
For larger or more complex osteochondral lesions of the talus, a surgical approach may be more appropriate. The Liquid Cartilage procedure — Professor Paul Lee's keyhole surgical protocol — uses the ChondroFiller scaffold delivered arthroscopically alongside biological adjuncts such as platelet-rich fibrin or platelet-rich plasma, and where indicated the patient's own mesenchymal stem cells. That is a distinct pathway involving theatre and a structured recovery, and is considered separately from the outpatient injection.
Why Timely Assessment Matters
Persistent ankle pain that does not settle warrants assessment rather than continued watchful waiting. Without addressing underlying cartilage damage, joint wear can progress. An early, personalised assessment with appropriate imaging helps identify whether the ChondroFiller injection, a surgical approach, or another form of management is most suitable for an individual's situation.
Conclusion
Persistent ankle pain after a sprain may be linked to cartilage damage within the joint that standard treatments have not addressed. The ChondroFiller injection is a non-surgical option that may provide biological support for worn joint surfaces in selected patients. A specialist assessment is the right starting point. For individual medical advice, please consult a qualified healthcare professional.
References
Weizel, A., Distler, T., Schneidereit, D., & Friedrich, O. (2020). Complex mechanical behavior of human articular cartilage and hydrogels for cartilage repair. Acta Biomaterialia.
Corain, M., Zanotti, F., Giardini, M., Gasperotti, L., Invernizzi, E., Biasi, V., & Lavagnolo, U. (2023). The use of an acellular collagen matrix ChondroFiller Liquid for trapeziometacarpal osteoarthritis. Cartilage.
Frequently Asked Questions
- Besides ligament damage, the cartilage inside the joint can also be affected at the time of injury. Because cartilage has limited blood supply, it heals slowly, and wear within the joint can cause ongoing pain, stiffness, or instability long after the sprain. Imaging helps identify whether cartilage damage is a contributing factor.
- The ankle is an accessible joint and cartilage damage here is often post-traumatic rather than due to widespread arthritis, which makes it well suited to the ultrasound-guided injection approach. The ChondroFiller scaffold may help support worn joint surfaces without the need for surgery, though it is not a cure and suitability depends on an individual assessment.
- No. The ChondroFiller injection is a non-surgical outpatient procedure using the ChondroFiller collagen scaffold delivered under ultrasound guidance. Liquid Cartilage is a separate, keyhole surgical protocol developed by Professor Paul Lee, in which the same scaffold is placed arthroscopically alongside biological adjuncts and, where indicated, the patient's own stem cells. They are distinct pathways suited to different clinical situations.
- Cartilage does not repair itself readily, and joint wear can progress if left unaddressed. An early assessment with appropriate imaging helps determine whether a non-surgical option such as the ChondroFiller injection is appropriate or whether a more involved approach is needed, allowing a plan to be put in place before the situation deteriorates.
- At the London Cartilage Clinic, a specialist assessment can determine whether the ChondroFiller injection or another management pathway is appropriate for your ankle. The clinic offers a thorough review of symptoms, imaging, and treatment history, with realistic guidance on likely outcomes.
Where to go from here
A few next steps tailored to what you have just read.
Legal & Medical Disclaimer
This article is written by an independent contributor and reflects their own views and experience, not necessarily those of London Cartilage Clinic. It is provided for general information and education only and does not constitute medical advice, diagnosis, or treatment.
Always seek personalised advice from a qualified healthcare professional before making decisions about your health. London Cartilage Clinic accepts no responsibility for errors, omissions, third-party content, or any loss, damage, or injury arising from reliance on this material.
If you believe this article contains inaccurate or infringing content, please contact us at [email protected].
